Automated red blood cell exchange for treatment of sickle cell disease

We are scoping the market to understand the availability of devices/products/systems for delivery of automated red cell exchange for patients with sickle cell disease, requiring regular red cell transfusion in the UK. Suppliers who feel their products/devices can offer this type of treatment should send a brief summary of their device to the email address provided in this PIN. Responses are requested no later than 19th January.